Risk-Based Monitoring: From the Road Less Traveled to Productivity Superhighway
Published: | Updated:
The latest news on the growing cost of conducting clinical trials is becoming a major concern for company sponsors and trial co-operative groups.
Mukhtar Ahmed
Advertisement
Mukhtar Ahmed is Vice President, Product Strategy, Oracle Health Sciences.
Articles by Mukhtar Ahmed
The Future is Now: Leveraging Machine-to-Machine Technology to Advance Clinical Trials
Published: | Updated:
Mukhtaer Ahmed outlines how advances in machine-to-machine (M2M) technologies have the potential to transform clinical development programs, including clinical trials.
Advertisement
Latest Updated Articles
- The Future is Now: Leveraging Machine-to-Machine Technology to Advance Clinical Trials
Published: October 22nd 2013 | Updated: November 15th 2020
- Risk-Based Monitoring: From the Road Less Traveled to Productivity Superhighway
Published: February 24th 2014 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options
2
The Ongoing Impact of MFN Pricing
3
Pharma Funding Roundup: Cognito Therapeutics Closes Oversubscribed $105 Million Series C Financing, Nexcure Launches $19 Million Series A Financing
4
Pharmaceutical Executive Daily: Pharma Industry's AI Adoption
5